2. Academic Validation
  3. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms

The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms

  • Sci Transl Med. 2018 Jan 10;10(423):eaan4044. doi: 10.1126/scitranslmed.aan4044.
Anna de Breij 1,  Martijn Riool 2,  Robert A Cordfunke 3,  Nermina Malanovic 4,  Leonie de Boer 2,  Roman I Koning 5 6,  Elisabeth Ravensbergen 1,  Marnix Franken 1,  Tobias van der Heijde 1,  Bouke K Boekema 7,  Paulus H S Kwakman 2,  Niels Kamp 8,  Abdelouahab El Ghalbzouri 9,  Karl Lohner 4,  Sebastian A J Zaat 2,  Jan W Drijfhout 3,  Peter H Nibbering 10
Affiliations

Affiliations

  • 1 Department of Infectious Diseases, Leiden University Medical Center, 2300 RC Leiden, Netherlands.
  • 2 Department of Medical Microbiology, Amsterdam Infection and Immunity Institute, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, Netherlands.
  • 3 Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2300 RC Leiden, Netherlands.
  • 4 Biophysics Division, Institute of Molecular Biosciences, University of Graz, Naturwissenschaftliche Fakultät (NAWI) Graz, BioTechMed, 8010 Graz, Austria.
  • 5 Department of Molecular Cell Biology, Leiden University Medical Center, 2300 RC Leiden, Netherlands.
  • 6 Netherlands Center for Electron Nanoscopy, Institute of Biology Leiden, Leiden University, 2300 RA Leiden, Netherlands.
  • 7 Association of Dutch Burn Centres, 1942 LT Beverwijk, Netherlands.
  • 8 Animal Research Institute, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, Netherlands.
  • 9 Department of Dermatology, Leiden University Medical Center, 2300 RC Leiden, Netherlands.
  • 10 Department of Infectious Diseases, Leiden University Medical Center, 2300 RC Leiden, Netherlands. p.h.nibbering@lumc.nl.
PMID: 29321257 DOI: 10.1126/scitranslmed.aan4044
Abstract

Development of novel antimicrobial agents is a top priority in the fight against multidrug-resistant (MDR) and persistent bacteria. We developed a panel of synthetic antimicrobial and antibiofilm Peptides (SAAPs) with enhanced antimicrobial activities compared to the parent peptide, human antimicrobial peptide LL-37. Our lead peptide SAAP-148 was more efficient in killing bacteria under physiological conditions in vitro than many known preclinical- and clinical-phase Antimicrobial Peptides. SAAP-148 killed MDR pathogens without inducing resistance, prevented biofilm formation, and eliminated established biofilms and persister cells. A single 4-hour treatment with hypromellose ointment containing SAAP-148 completely eradicated acute and established, biofilm-associated infections with methicillin-resistant Staphylococcus aureus and MDR Acinetobacter baumannii from wounded ex vivo human skin and murine skin in vivo. Together, these data demonstrate that SAAP-148 is a promising drug candidate in the battle against antibiotic-resistant bacteria that pose a great threat to human health.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z